Literature DB >> 29311276

Species-Specific Interactions of Arr with RplK Mediate Stringent Response in Bacteria.

Priyanka Agrawal1, Rajagopal Varada1, Shivjee Sah1, Souvik Bhattacharyya1, Umesh Varshney2,3.   

Abstract

Bacteria respond to stressful growth conditions through a conserved phenomenon of stringent response mediated by synthesis of stress alarmones ppGpp and pppGpp [referred to as (p)ppGpp]. (p)ppGpp synthesis is known to occur by ribosome-associated RelA. In addition, a dual-function protein, SpoT (with both synthetase and hydrolase activities), maintains (p)ppGpp homeostasis. The presence of (p)ppGpp is also known to contribute to antibiotic resistance in bacteria. Mycobacterium smegmatis possesses Arr, which inactivates rifampin by its ADP ribosylation. Arr has been shown to be upregulated in response to stress. However, the roles Arr might play during growth have remained unclear. We show that Arr confers growth fitness advantage to M. smegmatis even in the absence of rifampin. Arr deficiency in M. smegmatis resulted in deficiency of biofilm formation. Further, we show that while Arr does not interact with the wild-type Escherichia coli ribosomes, it interacts with them when the E. coli ribosomal protein L11 (a stringent response regulator) is replaced with its homolog from M. smegmatis The Arr interaction with E. coli ribosomes occurs even when the N-terminal 33 amino acids of its L11 protein were replaced with the corresponding sequence of M. smegmatis L11 (Msm-EcoL11 chimeric protein). Interestingly, Arr interaction with the E. coli ribosomes harboring M. smegmatis L11 or Msm-EcoL11 results in the synthesis of ppGpp in vivo Our study shows a novel role of antibiotic resistance gene arr in stress response.IMPORTANCEMycobacterium smegmatis, like many other bacteria, possesses an ADP-ribosyltransferase, Arr, which confers resistance to the first-line antituberculosis drug, rifampin, by its ADP ribosylation. In this report, we show that in addition to its known property of conferring resistance to rifampin, Arr confers growth fitness advantage to M. smegmatis even when there is no rifampin in the growth medium. We then show that Arr establishes species-specific interactions with ribosomes through the N-terminal sequence of ribosomal protein L11 (a stringent response regulator) and results in ppGpp (stress alarmone) synthesis. Deficiency of Arr in M. smegmatis results in deficiency of biofilm formation. Arr protein is physiologically important both in conferring antibiotic resistance as well as in mediating stringent response.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  (p)ppGpp; ADP-ribosyltransferase; metabolomics; mycobacteria; ppGpp; proteomics; ribosomal protein L11

Mesh:

Substances:

Year:  2018        PMID: 29311276      PMCID: PMC5826033          DOI: 10.1128/JB.00722-17

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  38 in total

1.  Residual guanosine 3',5'-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations.

Authors:  H Xiao; M Kalman; K Ikehara; S Zemel; G Glaser; M Cashel
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

Review 2.  (p)ppGpp: still magical?

Authors:  Katarzyna Potrykus; Michael Cashel
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

3.  Molecular dissection of the mycobacterial stringent response protein Rel.

Authors:  Vikas Jain; Raspudin Saleem-Batcha; Arnab China; Dipankar Chatterji
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

4.  The suppression of defective translation by ppGpp and its role in the stringent response.

Authors:  P H O'Farrell
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

5.  Two compounds implicated in the function of the RC gene of Escherichia coli.

Authors:  M Cashel; J Gallant
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

6.  Formation of merodiploids in matings with a class of Rec- recipient strains of Escherichia coli K12.

Authors:  B Low
Journal:  Proc Natl Acad Sci U S A       Date:  1968-05       Impact factor: 11.205

7.  The intrinsic resistance of Escherichia coli to various antimicrobial agents requires ppGpp and sigma s.

Authors:  D L Greenway; R R England
Journal:  Lett Appl Microbiol       Date:  1999-11       Impact factor: 2.858

8.  The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice.

Authors:  John L Dahl; Carl N Kraus; Helena I M Boshoff; Bernard Doan; Korrie Foley; David Avarbock; Gilla Kaplan; Valerie Mizrahi; Harvey Rubin; Clifton E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

9.  The RelA/SpoT homolog (RSH) superfamily: distribution and functional evolution of ppGpp synthetases and hydrolases across the tree of life.

Authors:  Gemma C Atkinson; Tanel Tenson; Vasili Hauryliuk
Journal:  PLoS One       Date:  2011-08-09       Impact factor: 3.240

10.  Worldwide emergence of extensively drug-resistant tuberculosis.

Authors:  N Sarita Shah; Abigail Wright; Gill-Han Bai; Lucia Barrera; Fadila Boulahbal; Nuria Martín-Casabona; Francis Drobniewski; Chris Gilpin; Marta Havelková; Rosario Lepe; Richard Lumb; Beverly Metchock; Françoise Portaels; Maria Filomena Rodrigues; Sabine Rüsch-Gerdes; Armand Van Deun; Veronique Vincent; Kayla Laserson; Charles Wells; J Peter Cegielski
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more
  2 in total

1.  Monomeric NADH-Oxidizing Methylenetetrahydrofolate Reductases from Mycobacterium smegmatis Lack Flavin Coenzyme.

Authors:  Shivjee Sah; Kuldeep Lahry; Chandana Talwar; Sudhir Singh; Umesh Varshney
Journal:  J Bacteriol       Date:  2020-05-27       Impact factor: 3.490

2.  Kanglemycin A Can Overcome Rifamycin Resistance Caused by ADP-Ribosylation by Arr Protein.

Authors:  John Harbottle; Hamed Mosaei; Nicholas Allenby; Nikolay Zenkin
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.